Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long‐term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithms
Norma Verdolini, Diego Hidalgo‐Mazzei, Laura Del Matto, et al.
Bipolar Disorders (2020) Vol. 23, Iss. 4, pp. 324-340
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Diagnosis and management of bipolar disorders
Fernando S. Goes
BMJ (2023), pp. e073591-e073591
Open Access | Times Cited: 65
Patterns of pharmacotherapy for bipolar disorder: A GBC survey
Balwinder Singh, Anastasia K. Yocum, Rebecca Strawbridge, et al.
Bipolar Disorders (2023) Vol. 26, Iss. 1, pp. 22-32
Open Access | Times Cited: 32
Why is lithium [not] the drug of choice for bipolar disorder? a controversy between science and clinical practice
Lars Vedel Kessing
International Journal of Bipolar Disorders (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 14
New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview
Analı́a Bortolozzi, Giovanna Fico, Michael Berk, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 323-357
Open Access | Times Cited: 10
Prevalence of impaired kidney function in patients with long‐term lithium treatment: A systematic review and meta‐analysis
Georgios Schoretsanitis, Renato de Filippis, Brian M. Brady, et al.
Bipolar Disorders (2021) Vol. 24, Iss. 3, pp. 264-274
Closed Access | Times Cited: 49
Lithium therapy and weight change in people with bipolar disorder: A systematic review and meta-analysis
Susana Gomes‐da‐Costa, Wolfgang Marx, Filippo Corponi, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 134, pp. 104266-104266
Open Access | Times Cited: 43
Bipolar Disorder
Mark S. Bauer
Annals of Internal Medicine (2022) Vol. 175, Iss. 7, pp. ITC97-ITC112
Closed Access | Times Cited: 28
Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis
Chih‐Wei Hsu, Shang‐Ying Tsai, Ping‐Tao Tseng, et al.
European Neuropsychopharmacology (2022) Vol. 58, pp. 20-29
Closed Access | Times Cited: 24
Evaluating the efficacy and safety of the currently available once-every-two months long-acting injectable formulations of aripiprazole for the treatment of schizophrenia or as a maintenance monotherapy for bipolar I disorder in adults
Ludovic Samalin, Ludivine Boudieu, Pierre‐Michel Llorca
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 3, pp. 291-298
Closed Access | Times Cited: 4
Linking Mitochondrial Dysfunction, Neurotransmitter, and Neural Network Abnormalities and Mania: Elucidating Neurobiological Mechanisms of the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder
Zachary Freyberg, Ana C. Andreazza, Colleen A. McClung, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024) Vol. 10, Iss. 3, pp. 267-277
Closed Access | Times Cited: 4
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics
Marco Carli, Francesco Weiss, Giovanna Grenno, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 4, pp. 935-950
Open Access | Times Cited: 10
Left Ventrolateral Prefrontal Cortical Activity During Reward Expectancy and Mania Risk
Manan Arora, Henry W. Chase, Michele A. Bertocci, et al.
JAMA Psychiatry (2025) Vol. 82, Iss. 3, pp. 274-274
Closed Access
Pushing Past the Extinction Burst: Extreme Dysregulation in Inpatient Treatment of ARFID
Kimberley Elaine Ward, Lisa Adler, Alexis Escalera, et al.
Clinical Case Studies (2025)
Closed Access
Optimization of Therapy in Patients with Epilepsy and Psychiatric Comorbidities: Key Points
Francesco Pisani, Laura Rosa Pisani, María Antonietta Barbieri, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 8, pp. 1755-1766
Open Access | Times Cited: 15
Machine Learning Prediction of Comorbid Substance Use Disorders among People with Bipolar Disorder
Vincenzo Oliva, Michele De Prisco, Maria Teresa Pons‐Cabrera, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 14, pp. 3935-3935
Open Access | Times Cited: 14
Duration of untreated illness and bipolar disorder: time for a new definition? Results from a cross-sectional study
Giovanna Fico, Gerard Anmella, Marta Gómez-Ramiro, et al.
Journal of Affective Disorders (2021) Vol. 294, pp. 513-520
Open Access | Times Cited: 18
Undetermined predominant polarity in a cohort of bipolar disorder patients: Prevalent, severe, and overlooked
Giovanna Fico, Gerard Anmella, Maria Sagué-Villavella, et al.
Journal of Affective Disorders (2022) Vol. 303, pp. 223-229
Closed Access | Times Cited: 10
Existing and emerging pharmacological approaches to the treatment of mania: A critical overview
Giulio Sparacino, Norma Verdolini, Eduard Vieta, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Prophylactic Management of Women With Bipolar Disorder During Pregnancy and the Perinatal Period
Faruk Uğuz, Verinder Sharma, Philip Boyce, et al.
Journal of Clinical Psychopharmacology (2023) Vol. 43, Iss. 5, pp. 434-452
Closed Access | Times Cited: 5
Target Discovery Using Deep Learning-Based Molecular Docking and Predicted Protein Structures With AlphaFold for Novel Antipsychotics
Yangsik Kim, Seyong Kim
Psychiatry Investigation (2023) Vol. 20, Iss. 6, pp. 504-514
Open Access | Times Cited: 4
Lithium Dispensed for Adults Aged ≥ 50 Years Between 2012 and 2021: Analyses of a 10% Sample of the Australian Pharmaceutical Benefits Scheme
Osvaldo P. Almeida, Christopher Etherton‐Beer, Erin Kelty, et al.
American Journal of Geriatric Psychiatry (2023) Vol. 31, Iss. 9, pp. 716-725
Closed Access | Times Cited: 3
Clozapine Use for Bipolar Disorder
Lek Wei Javier Loo, Qian Hui Chew, Shih‐Ku Lin, et al.
Journal of Clinical Psychopharmacology (2023) Vol. 43, Iss. 3, pp. 278-282
Closed Access | Times Cited: 3
Lithium produces bi-directionally regulation of mood disturbance, acts synergistically with anti-depressive/-manic agents, and did not deteriorate the cognitive impairment in murine model of bipolar disorder
Chuanjun Zhuo, Chunhua Zhou, Hongjun Tian, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Pharmacological Treatment of Bipolar Depression: A Review of Observational Studies
Frederike T. Fellendorf, Edoardo Caboni, Pasquale Paribello, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 182-182
Open Access | Times Cited: 2
Critical appraisal and comparison of recommendations of clinical practice guidelines for the treatment of schizophrenia in children and adolescents: a methodological survey
Maíra Ramos Alves, Cristiane de Cássia Bergamaschi, Silvio Barberato‐Filho, et al.
BMJ Open (2023) Vol. 13, Iss. 2, pp. e070332-e070332
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top